Cargando…

An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis

Mycobacterium tuberculosis (M.tb), a bacterial pathogen that causes tuberculosis disease (TB), exerts an extensive burden on global health. The complex nature of M.tb, coupled with different TB disease stages, has made identifying immune correlates of protection challenging and subsequently slowing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsen, Sasha E., Erasmus, Jesse H., Reese, Valerie A., Pecor, Tiffany, Archer, Jacob, Kandahar, Amit, Hsu, Fan-Chi, Nicholes, Katrina, Reed, Steven G., Baldwin, Susan L., Coler, Rhea N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862644/ https://www.ncbi.nlm.nih.gov/pubmed/36679975 http://dx.doi.org/10.3390/vaccines11010130

Ejemplares similares

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment
por: Larsen, Sasha E., et al.
Publicado: (2018)

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
por: Baldwin, Susan L., et al.
Publicado: (2022)

Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event
por: Berube, Bryan J., et al.
Publicado: (2022)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
por: Baldwin, Susan L., et al.
Publicado: (2021)

Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models
por: Larsen, Sasha E., et al.
Publicado: (2021)

Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
por: Larsen, Sasha E., et al.
Publicado: (2023)

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
por: Larsen, Sasha E., et al.
Publicado: (2022)

Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model
por: Kwon, Kee Woong, et al.
Publicado: (2019)

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
por: Baldwin, Susan L., et al.
Publicado: (2019)

Mycobacterium abscessus: It’s Complex
por: Abdelaal, Hazem F. M., et al.
Publicado: (2022)

Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
por: Larsen, Sasha E., et al.
Publicado: (2021)

Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
por: Larsen, Sasha E., et al.
Publicado: (2021)

Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human Cd4(+) T Cells
por: Alderson, Mark R., et al.
Publicado: (2000)

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection
por: Baldwin, Susan L., et al.
Publicado: (2018)

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
por: Choi, Yu Hwa, et al.
Publicado: (2023)

Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
por: Armistead, Blair, et al.
Publicado: (2022)

Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology
por: Dijkman, Karin, et al.
Publicado: (2022)

Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
por: Armistead, Blair, et al.
Publicado: (2023)

Abstract 1647: Quantification of functional antibody titers in a mouse model of SARS-CoV-2 infection
por: Hernandez, Dulce, et al.
Publicado: (2023)

Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
por: Erasmus, Jesse H., et al.
Publicado: (2020)

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
por: Orr, Mark T., et al.
Publicado: (2014)

Pervasive translation in Mycobacterium tuberculosis
por: Smith, Carol, et al.
Publicado: (2022)

SARS-CoV-2 infection and immune responses
por: Harne, Rakhi, et al.
Publicado: (2023)

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
por: Fox, Christopher B., et al.
Publicado: (2012)

Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease
por: Lee, Ju Mi, et al.
Publicado: (2022)

Mycobacterium tuberculosis and the host response
por: Kaufmann, Stefan H.E., et al.
Publicado: (2005)

Mycobacterium tuberculosis Alters the Metalloprotease Activity of the COP9 Signalosome
por: Danelishvili, Lia, et al.
Publicado: (2014)

Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates
por: Broda, Agnieszka, et al.
Publicado: (2018)

New serological platform for detecting antibodies against Mycobacterium tuberculosis complex in European badgers
por: Infantes‐Lorenzo, Jose A., et al.
Publicado: (2019)

Novel Assay Platform to Evaluate Intracellular Killing of Mycobacterium tuberculosis: In Vitro and In Vivo Validation
por: Horváti, Kata, et al.
Publicado: (2021)

Death of Mycobacterium tuberculosis by l-arginine starvation
por: Mizrahi, Valerie, et al.
Publicado: (2018)

Iron homeostasis in Mycobacterium tuberculosis is essential for persistence
por: Pandey, Manitosh, et al.
Publicado: (2018)

Cytokinin Signaling in Mycobacterium tuberculosis
por: Samanovic, Marie I., et al.
Publicado: (2018)

Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)

Mycobacterium Tuberculosis in Spinal Tuberculosis
por: Moon, Myung-Sang, et al.
Publicado: (2017)

760. The Diversity of Mycobacterium tuberculosis in India Is Underestimated and Underreported
por: Poonawala, Husain, et al.
Publicado: (2018)

Detection of Mycobacterium tuberculosis on stool specimens by PCR among patients with pulmonary tuberculosis
por: Kesarwani, Vasudha, et al.
Publicado: (2022)

A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2016)

Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins
por: Piubelli, Luciano, et al.
Publicado: (2013)

Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System
por: Wang, Hye-young, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lq4mgvq1moivl64888le84mapk